BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.090
-0.060 (-1.45%)
At close: Sep 22, 2026, 4:00 PM EDT
4.150
+0.060 (1.47%)
After-hours: Sep 22, 2026, 7:30 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $35.5 million as of September 22, 2026. Its market cap has increased by 472.56% in one year.
Market Cap
35.50M
Enterprise Value
12.80M
1-Year Change
472.56%
Ranking
Category
Stock Price
$4.09
ChartMarket Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $35.50M, an increase of 36.53%. That is a compound annual growth rate of 5.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 35.50M | 164.91% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 41.09M |
| Immutep | 39.81M |
| Seres Therapeutics | 39.77M |
| Lite Strategy | 38.45M |
| Actinium Pharmaceuticals | 38.36M |
| Celularity | 37.92M |
| CervoMed | 36.74M |
| aTyr Pharma | 35.61M |